Literature DB >> 34404905

Immunohistochemical staining patterns of p53 predict the mutational status of TP53 in oral epithelial dysplasia.

Keisuke Sawada1, Shuji Momose2, Ryutaro Kawano1, Masakazu Kohda3, Tarou Irié4, Kenji Mishima5, Takahiro Kaneko6, Norio Horie6, Yasushi Okazaki3, Morihiro Higashi1, Jun-Ichi Tamaru1.   

Abstract

Next-generation sequencing of oral squamous cell carcinoma (OSCC) has revealed TP53 as the most frequently mutated gene in OSCC mutually exclusive with human papillomavirus infection. Oral epithelial dysplasia (OED) is defined as a precancerous lesion of OSCC by the current World Health Organization (WHO) classification; therefore, it is assumed that TP53 mutations occur in early precancerous conditions such as OED. Here, we conducted an integrated analysis of TP53, including whole coding sequencing of TP53, FISH analysis of the 17p13.1 locus, and immunohistochemical analysis for p53 (p53-IHC), in 40 OED cases. We detected 20 mutations in 16 (40%) OED cases, and four cases, each harbored two mutations. FISH analysis revealed six of 24 cases (25%) had a deletion on 17p13.1, and four cases had concurrent TP53 mutations and 17p13.1 deletion (2-hit). Also, the increased frequency of TP53 mutations in higher degrees of OED implies acquisition of the mutation is a major event toward OSCC. p53-IHC revealed that overall cases could be categorized into four patterns that correlate well with the mutational status of TP53. Especially, two patterns, broad p53 expression type (pattern HI) and p53 null type (pattern LS), strongly correlated with a missense mutation and nonsense mutation, respectively. Furthermore, seven of the 40 cases progressed to SCC, and six of these seven cases presented pattern HI or LS. Therefore, patterns HI and LS have a high risk for malignant transformation if excisional treatment is not performed irrespective of the dysplasia grade. Although the current WHO classification mainly focuses on morphological criteria for the diagnosis of OED, interobserver discrepancy appears in some instances of the OED diagnosis. Our immunohistochemical analysis supports a more accurate pathological diagnosis for OED in cases of low dysplastic changes or of differential diagnosis with non-dysplastic lesions.
© 2021. The Author(s), under exclusive licence to United States & Canadian Academy of Pathology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34404905     DOI: 10.1038/s41379-021-00893-9

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  49 in total

1.  Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.

Authors:  M P Rosin; X Cheng; C Poh; W L Lam; Y Huang; J Lovas; K Berean; J B Epstein; R Priddy; N D Le; L Zhang
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

2.  Update on oral epithelial dysplasia and progression to cancer.

Authors:  Paul M Speight
Journal:  Head Neck Pathol       Date:  2007-11-30

3.  Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients.

Authors:  Erea Brouns; Ja Baart; Kh Karagozoglu; Iha Aartman; E Bloemena; I van der Waal
Journal:  Oral Dis       Date:  2013-03-25       Impact factor: 3.511

4.  Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions.

Authors:  Dena J Fischer; Joel B Epstein; Thomas H Morton; Stephen M Schwartz
Journal:  J Oral Pathol Med       Date:  2004-02       Impact factor: 4.253

5.  Observer variability in the histologic assessment of oral premalignant lesions.

Authors:  A Karabulut; J Reibel; M H Therkildsen; F Praetorius; H W Nielsen; E Dabelsteen
Journal:  J Oral Pathol Med       Date:  1995-05       Impact factor: 4.253

6.  Nomenclature and classification of potentially malignant disorders of the oral mucosa.

Authors:  S Warnakulasuriya; Newell W Johnson; I van der Waal
Journal:  J Oral Pathol Med       Date:  2007-11       Impact factor: 4.253

7.  Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.

Authors:  K P Schepman; E H van der Meij; L E Smeele; I van der Waal
Journal:  Oral Oncol       Date:  1998-07       Impact factor: 5.337

8.  Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.

Authors:  Anil K Chaturvedi; Natalia Udaltsova; Eric A Engels; Jed A Katzel; Elizabeth L Yanik; Hormuzd A Katki; Mark W Lingen; Michael J Silverberg
Journal:  J Natl Cancer Inst       Date:  2020-10-01       Impact factor: 13.506

9.  Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement.

Authors:  S Warnakulasuriya; J Reibel; J Bouquot; E Dabelsteen
Journal:  J Oral Pathol Med       Date:  2008-03       Impact factor: 4.253

10.  Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.

Authors:  Yen-Yun Wang; Yen-Hsuan Tail; Wen-Chen Wang; Ching-Yi Chen; Yu-Hsun Kao; Yuk-Kwan Chen; Chung-Ho Chen
Journal:  BMC Oral Health       Date:  2014-08-05       Impact factor: 2.757

View more
  4 in total

1.  Cancer cells corrupt normal epithelial cells through miR-let-7c-rich small extracellular vesicle-mediated downregulation of p53/PTEN.

Authors:  Weilian Liang; Yang Chen; Hanzhe Liu; Hui Zhao; Tingting Luo; Hokeung Tang; Xiaocheng Zhou; Erhui Jiang; Zhe Shao; Ke Liu; Zhengjun Shang
Journal:  Int J Oral Sci       Date:  2022-07-19       Impact factor: 24.897

Review 2.  Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy.

Authors:  Roberto Rangel; Curtis R Pickering; Andrew G Sikora; Michael T Spiotto
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 8.786

3.  Synchronous Jejunal Sarcomatoid Carcinoma and Incidentally Associated Localized Peritoneal Malignant Mesothelioma.

Authors:  Mitsuhiro Tachibana; Masashi Nozawa; Kazuyasu Kamimura; Yutaka Tsutsumi
Journal:  Cureus       Date:  2022-06-24

4.  Case Report: Papillary Lesions at the Mouth Floor May Mimic Sialadenoma Papilliferum.

Authors:  Dawool Han; Eunae Sandra Cho; Jiho Park; Dongwook Kim
Journal:  Pathol Oncol Res       Date:  2022-07-14       Impact factor: 2.874

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.